Cargando…

Detection and Identification of Hematologic Malignancies and Solid Tumors by an Electrochemical Technique

PURPOSE: Develop and evaluate an electrochemical method to identify healthy individuals, malignant hematopathic patients and solid tumor patients by detecting the leukocytes in whole-blood. METHODS: A total of 114 individual blood samples obtained from our affiliated hospital in China (June 2015- Au...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yujie, Zhang, Bowen, Zhang, Xiaoping, Wang, Xuemei, Cheng, Jian, Chen, Baoan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845976/ https://www.ncbi.nlm.nih.gov/pubmed/27115355 http://dx.doi.org/10.1371/journal.pone.0153821

Ejemplares similares

Biocompatibility of Fe(3)O(4)/DNR magnetic nanoparticles in the treatment of hematologic malignancies
por: Wu, Weiwei, et al.
Publicado: (2010)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy
por: Cui, Yuehong, et al.
Publicado: (2012)

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors
por: Federico, Mario, et al.
Publicado: (2011)

Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies
por: Mancini, Stéphane J.C., et al.
Publicado: (2021)

Hematologic malignancies following immune checkpoint inhibition for solid tumors
por: van Eijs, Mick J. M., et al.
Publicado: (2022)

Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors
por: Lin, Swan, et al.
Publicado: (2019)

Thirty-Two Case Reports of Synchronous Hematological Malignancy and Solid Tumor
por: Liu, Sha, et al.
Publicado: (2019)

Ferroptosis in hematological malignant tumors
por: Liu, Yong, et al.
Publicado: (2023)

Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
por: Zhang, Yi, et al.
Publicado: (2023)

Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies
por: McBride, Ali, et al.
Publicado: (2012)

The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies
por: Shaw, Jaime L., et al.
Publicado: (2021)

PPM1D in Solid and Hematologic Malignancies: Friend and Foe?
por: Zhang, Linda, et al.
Publicado: (2022)

Recent Development of Graphene Based Electrochemical Sensor for Detecting Hematological Malignancies-Associated Biomarkers: A Mini-Review
por: Wei, Shougang, et al.
Publicado: (2021)

Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy
por: Di Martino, Maria Teresa, et al.
Publicado: (2018)

A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumor s and hematologic malignancies
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid Tumors
por: Ravi, Dashnamoorthy, et al.
Publicado: (2022)

The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies
por: Zhou, Qinfeng, et al.
Publicado: (2022)

Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation
por: Bao, Wen, et al.
Publicado: (2019)

Evaluation of the factors affecting the prognosis of patients with solid tumors and hematologic malignancies in the intensive care unit
por: Savran, Y, et al.
Publicado: (2015)

Role of Chemoports in Children with Hematological/Solid Tumor Malignancies - Technical Implications and Complications: An Institutional Experience
por: Redkar, Rajeev, et al.
Publicado: (2019)

Nutritional status of children and adolescents at diagnosis of hematological and solid malignancies
por: Lemos, Priscila dos Santos Maia, et al.
Publicado: (2014)

Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies
por: Allegra, Alessandro, et al.
Publicado: (2022)

Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies
por: Marei, Hany E., et al.
Publicado: (2023)

Characteristics of pathogens detected in adults with hematological malignancies and nosocomial infections in the tropics
por: Dou, Li-Ping, et al.
Publicado: (2020)

Prognostic Role of the Activated p-AKT Molecule in Various Hematologic Malignancies and Solid Tumors: A Meta-Analysis
por: Yao, Zhen, et al.
Publicado: (2020)

Applications of electrochemical biosensors based on 2D materials and their hybrid composites in hematological malignancies diagnosis
por: Sun, Caixia, et al.
Publicado: (2022)

CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies
por: Ma, Xuefei, et al.
Publicado: (2022)

Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic Malignancies
por: Ruiz‐Garcia, Ana, et al.
Publicado: (2020)

Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors
por: Royo-Cebrecos, Cristina, et al.
Publicado: (2022)

Oral colonization by gram-negative bacilli in patients with hematologic malignancies and solid tumors compared with healthy controls
por: Santibañez-Bedolla, Karla E., et al.
Publicado: (2023)

Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors
por: Sun, Li-Yue, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies
por: Ellis, Leigh, et al.
Publicado: (2010)

Acute Respiratory Failure in Patients with Hematologic and Solid Malignancies: Global Approach
por: Sethi, Sakshi, et al.
Publicado: (2017)

Risk of infection associated with targeted therapies for solid organ and hematological malignancies
por: Ruiz-Camps, Isabel, et al.
Publicado: (2021)

Advances in early detection methods for solid tumors
por: Jiang, Bowen, et al.
Publicado: (2023)

Correlation between lymphoma and second primary malignant tumor
por: Liu, Lingjuan, et al.
Publicado: (2023)

Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies
por: Xie, Yutong, et al.
Publicado: (2022)

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
por: Chee, Cheng E., et al.
Publicado: (2023)

Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials
por: Sun, Yanli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v5kep6gn4cq9eool819t3mffrb